RUBICONPharmaceuticals

Rubicon ResearchShareholding Pattern

640.20
+0.00%
Promoter59.99%↓ -24.16% QoQ
FII9.38%No change
DII10.54%No change
Public20.09%Retail & others
🥧

Shareholding Structure

HoldingsSplit
Promoter
59.99%
FII
9.38%
DII
10.54%
Public
20.09%
📊

Quarter-on-Quarter Changes

Promoter Holding
59.99%
↓ -24.16%
FII Holding
9.38%
→ No change
DII Holding
10.54%
→ No change
💡

What This Means

Rubicon Research (RUBICON) has promoter holding of 59.99%. High promoter holding indicates strong founder confidence and alignment with minority shareholders. Promoters reduced stake by -24.16% this quarter — monitor for further reduction. Shareholding changes every quarter are filed with BSE/NSE. Educational data only.

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.